SCLX Q3 2023 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena

SCLXScilex Holding Company

$73M

Q3 2023 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$10M-11.1% YoY

Gross Profit

$7M66.5% margin

Operating Income

-$39M-383.6% margin

Net Income

-$36M-351.2% margin

EPS (Diluted)

$-8.89

QoQ Revenue Growth

-19.6%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$6M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$81M

Total Liabilities

$243M

Stockholders' Equity

-$163M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$11M	-11.1%
Gross Profit	$7M	$8M	-13.4%
Operating Income	-$39M	-$11M	-265.5%
Net Income	-$36M	$22M	-265.2%